Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Br J Nutr ; 106 Suppl 3: S5-78, 2011 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-22133051

RESUMEN

Low-grade inflammation is a characteristic of the obese state, and adipose tissue releases many inflammatory mediators. The source of these mediators within adipose tissue is not clear, but infiltrating macrophages seem to be especially important, although adipocytes themselves play a role. Obese people have higher circulating concentrations of many inflammatory markers than lean people do, and these are believed to play a role in causing insulin resistance and other metabolic disturbances. Blood concentrations of inflammatory markers are lowered following weight loss. In the hours following the consumption of a meal, there is an elevation in the concentrations of inflammatory mediators in the bloodstream, which is exaggerated in obese subjects and in type 2 diabetics. Both high-glucose and high-fat meals may induce postprandial inflammation, and this is exaggerated by a high meal content of advanced glycation end products (AGE) and partly ablated by inclusion of certain antioxidants or antioxidant-containing foods within the meal. Healthy eating patterns are associated with lower circulating concentrations of inflammatory markers. Among the components of a healthy diet, whole grains, vegetables and fruits, and fish are all associated with lower inflammation. AGE are associated with enhanced oxidative stress and inflammation. SFA and trans-MUFA are pro-inflammatory, while PUFA, especially long-chain n-3 PUFA, are anti-inflammatory. Hyperglycaemia induces both postprandial and chronic low-grade inflammation. Vitamin C, vitamin E and carotenoids decrease the circulating concentrations of inflammatory markers. Potential mechanisms are described and research gaps, which limit our understanding of the interaction between diet and postprandial and chronic low-grade inflammation, are identified.


Asunto(s)
Dieta , Obesidad/etiología , Obesidad/inmunología , Sobrepeso/etiología , Sobrepeso/inmunología , Envejecimiento , Animales , Dieta/efectos adversos , Manipulación de Alimentos , Productos Finales de Glicación Avanzada/efectos adversos , Productos Finales de Glicación Avanzada/sangre , Productos Finales de Glicación Avanzada/metabolismo , Humanos , Resistencia a la Insulina , Peroxidación de Lípido , Actividad Motora , Obesidad/sangre , Obesidad/metabolismo , Sobrepeso/sangre , Sobrepeso/metabolismo , Peróxidos/efectos adversos
2.
Food Chem Toxicol ; 50 Suppl 4: S710-23, 2012 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-21763387

RESUMEN

The respective examples, described in this paper, illustrate how the BRAFO-tiered approach, on benefit-risk assessment, can be tested on a wide range of case studies. Various results were provided, ranging from a quick stop as the result of non-genuine benefit-risk questions to continuation through the tiers into deterministic/probabilistic calculations. The paper illustrates the assessment of benefits and risks associated with dietary interventions. The BRAFO tiered approach is tested with five case studies. In each instance, the benefit-risk approach is tested on the basis of existing evaluations for the individual effects done by others; no new risk or benefit evaluations were made. The following case studies were thoroughly analysed: an example of food fortification, folic acid fortification of flour, macronutrient replacement/food substitution; the isocaloric replacement of saturated fatty acids with carbohydrates; the replacement of saturated fatty acids with monounsaturated fatty acids; the replacement of sugar-sweetened beverages containing mono- and disaccharides with low calorie sweeteners and an example of addition of specific ingredients to food: chlorination of drinking water.


Asunto(s)
Dieta , Medición de Riesgo/métodos , Pan , Restricción Calórica , Enfermedades Cardiovasculares/etiología , Enfermedades Cardiovasculares/prevención & control , Cloro/efectos adversos , Cloro/análisis , Carbohidratos de la Dieta/administración & dosificación , Carbohidratos de la Dieta/efectos adversos , Grasas de la Dieta/administración & dosificación , Grasas de la Dieta/efectos adversos , Agua Potable/efectos adversos , Agua Potable/química , Ingestión de Energía , Europa (Continente) , Ácidos Grasos Monoinsaturados/administración & dosificación , Femenino , Ácido Fólico/administración & dosificación , Ácido Fólico/efectos adversos , Alimentos Fortificados , Promoción de la Salud , Humanos , Neoplasias/etiología , Embarazo , Edulcorantes/administración & dosificación , Edulcorantes/efectos adversos , Pérdida de Peso
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA